Segment Information (Tables)

12 Months Ended

Jun. 30, 2015

Segment Reporting [Abstract]

Schedule of segment performance measures

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2015
Net sales	$	225,263	$	149,296	$	172,392	$	-		$	546,951
Gross profit		75,749		26,683		33,002		-			135,434
Income before income taxes		35,152		8,697		14,289		(4,273	)		53,865
2014
Net sales	$	160,217	$	176,425	$	173,537	$	-		$	510,179
Gross profit		48,496		36,615		29,592		-			114,703
Income before income taxes		19,710		17,557		13,273		(5,866	)		44,674
2013
Net sales	$	129,667	$	184,852	$	185,171	$	-		$	499,690
Gross profit		39,306		31,367		27,598		-			98,271
Income before income taxes		17,276		13,294		10,400		(6,420	)		34,550

Schedule of net sales and gross profit by source country

Net Sales							Gross Profit
	2015		2014		2013			2015		2014		2013
United States	$	407,101	$	355,715	$	326,247		$	111,734	$	82,573	$	68,964
Germany		69,889		84,024		92,053			14,660		22,614		19,688
Netherlands		14,656		14,869		14,513			1,325		1,581		1,693
France		27,976		29,412		38,475			3,634		4,182		4,608
Asia-Pacific		27,329		26,159		28,402			4,081		3,753		3,318
Total	$	546,951	$	510,179	$	499,690		$	135,434	$	114,703	$	98,271

Schedule of long-lived assets by geographic region

	Long-lived assets
		2015		2014
United States		$	152,886	$	160,544
Europe			2,544		3,458
Asia-Pacific			1,893		2,042
Total		$	157,323	$	166,044